Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robotic Assisted Bronchoscopy with Endobronchial Ultrasound for the Evaluation of Multiple Pulmonary Nodules: A Multi-Center Registry.

Annals of the American Thoracic Society·2026
Same author

Turnaround Time of Comprehensive Genomic Profiling in Lung Cancer and Other Solid Tumors.

JCO oncology practice·2026
Same author

Evaluation of an artificial intelligence generated Brock score to determine malignancy risk of screen-detected pulmonary nodules.

European journal of radiology open·2026
Same author

State Variation in the Incidence of Small Cell Lung Cancer and Its Association With Smoking.

Chest·2026
Same author

The American Cancer Society National Lung Cancer Roundtable strategic plan: Challenges in clinical guideline recommendations for biomarker testing in lung cancer.

Cancer·2026
Same author

Network-based analysis of images and lesions expressed by digital interpretation and transmission of bronchoscopy findings on social media (NAILED-IT).

Respiratory medicine·2026

Related Experiment Video

Updated: Jun 16, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K

Biomarker Testing for Guiding Precision Medicine for Patients With Non-Small Cell Lung Cancer.

Adam H Fox1, Mariam Alexander2, Jessica A Forcucci3

  • 1Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Medical University of South Carolina, Charleston, SC.

Chest
|August 16, 2024
PubMed
Summary

Pulmonologists need to understand biomarker testing for lung cancer management. This review guides them on incorporating essential biomarker tests for precision medicine in lung cancer patients.

Keywords:
biomarkernon-small cell lung cancerprecision medicinetargeted therapies

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.1K

Related Experiment Videos

Last Updated: Jun 16, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.1K

Area of Science:

  • Oncology
  • Pulmonology
  • Genetics

Background:

  • Lung cancer management is increasingly complex due to precision medicine advancements.
  • Biomarker testing is now essential for lung cancer patients across various stages.
  • Pulmonologists play a key role in initial lung cancer patient management.

Purpose of the Study:

  • To provide fundamental knowledge on biomarker testing for lung cancer.
  • To guide the incorporation of biomarker testing into diagnostic and staging evaluations.
  • To offer strategies for multidisciplinary team collaboration for timely testing.

Main Methods:

  • Literature review on biomarker testing in lung cancer.
  • Analysis of current guidelines and clinical practice.
  • Synthesis of information for educational purposes.

Main Results:

  • Biomarker testing is crucial for selecting targeted therapies.
  • Understanding histology and stage is vital for appropriate test selection.
  • Multidisciplinary collaboration ensures comprehensive and timely testing.

Conclusions:

  • Pulmonologists require foundational knowledge of biomarker testing.
  • Integrating biomarker testing early improves lung cancer treatment efficacy.
  • Effective teamwork is key to leveraging precision medicine in lung cancer care.